QR code

MET Amplification and Efficacy of Nivolumab in Patients With NSCLC

Introduction: MET amplification is an important genetic alteration in NSCLC. Unlike in patients with EGFR and ALK alterations, the efficacy of immune checkpoint inhibitors in patients with MET-amplified NSCLC remains unknown. Methods: An exploratory analysis of a prospective, multi-institutional coh...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Katsuhiro Yoshimura, MD, PhD, Yusuke Inoue, MD, PhD, Naoki Inui, MD, PhD, Masato Karayama, MD, PhD, Hideki Yasui, MD, PhD, Hironao Hozumi, MD, PhD, Yuzo Suzuki, MD, PhD, Kazuki Furuhashi, MD, PhD, Tomoyuki Fujisawa, MD, PhD, Noriyuki Enomoto, MD, PhD, Yutaro Nakamura, MD, PhD, Haruhiko Sugimura, MD, PhD, Takafumi Suda, MD, PhD
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier 2021-11-01
Reeks:JTO Clinical and Research Reports
Onderwerpen:
Lung cancer
MET
Nivolumab
Amplification
Immune checkpoint inhibitor
Online toegang:http://www.sciencedirect.com/science/article/pii/S2666364321000989
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items